Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 112 institutions that hold shares in the stock, with a total of 92.4 Million shares, which have been reported (via 13F filing form) to have a value of $135 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northwestern Mutual Wealth Management CO
|
May 14, 2025 Q1 2025 |
500
shares
|
$730
0.0% of portfolio
|
Q1 2020
New holding
|
|
|
Capital Advisors, Ltd. LLC
|
Apr 15, 2025 Q1 2025 |
454
shares
|
$662
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Nisa Investment Advisors, LLC
|
Apr 30, 2025 Q1 2025 |
318
shares
|
$464
0.0% of portfolio
|
Q3 2024
Reduced 39.66%
|
|
|
Truvestments Capital LLC
Sarasota, FL |
May 14, 2025 Q1 2025 |
150
shares
|
$219
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Jul 11, 2025 Q2 2025 |
99
shares
|
$144
0.0% of portfolio
|
Q1 2024
Added 52.31%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
68
shares
|
$99
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
67
shares
|
$97
0.0% of portfolio
|
Q1 2025
Added 1.52%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2025 Q1 2025 |
46
shares
|
$67
0.0% of portfolio
|
Q1 2025
Reduced 94.05%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|